Literature DB >> 22506096

Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

Rolando E Yanes1, Fuyuhiko Tamanoi.   

Abstract

The development of delivery vehicles that would carry therapeutic agents selectively to cancer cells has become an important focus in biomedical research. Nanoparticles have received much attention because the advances made in this field have resulted in multiple biocompatible materials. In particular, mesoporous silica nanoparticles (MSNs) offer a solid framework with porous structure and high surface area that allows for the attachment of different functional groups. In this article we discuss the different surface modifications made to MSNs that have allowed for the construction of targeted nanoparticles to enhance accumulation and uptake in target sites, the incorporation of nanomachines for controlled cargo release and the combination with superparamagnetic metals for MRI cell labeling. We also discuss biocompatibility, biodistribution and drug-delivery efficacy of MSNs. Finally, we mention the construction of multifunctional nanoparticles that combine all of the previously examined nanoparticle modifications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22506096      PMCID: PMC3324307          DOI: 10.4155/tde.12.9

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  78 in total

1.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics.

Authors:  Chia-Hung Lee; Shih-Hsun Cheng; I-Ping Huang; Jeffrey S Souris; Chung-Shi Yang; Chung-Yuan Mou; Leu-Wei Lo
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-25       Impact factor: 15.336

Review 2.  Quantum dots as cellular probes.

Authors:  A Paul Alivisatos; Weiwei Gu; Carolyn Larabell
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

3.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.

Authors:  Hyon Bin Na; Jung Hee Lee; Kwangjin An; Yong Il Park; Mihyun Park; In Su Lee; Do-Hyun Nam; Sung Tae Kim; Seung-Hoon Kim; Sang-Wook Kim; Keun-Ho Lim; Ki-Soo Kim; Sun-Ok Kim; Taeghwan Hyeon
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 4.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Authors:  Igor I Slowing; Juan L Vivero-Escoto; Chia-Wen Wu; Victor S-Y Lin
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

5.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.

Authors:  Xinglu Huang; Linlin Li; Tianlong Liu; Nanjing Hao; Huiyu Liu; Dong Chen; Fangqiong Tang
Journal:  ACS Nano       Date:  2011-06-08       Impact factor: 15.881

Review 6.  Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.

Authors:  Monica Vialpando; Johan A Martens; Guy Van den Mooter
Journal:  Ther Deliv       Date:  2011-08

Review 7.  Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications.

Authors:  Chenjie Xu; Shouheng Sun
Journal:  Dalton Trans       Date:  2009-05-01       Impact factor: 4.390

8.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Authors:  Chunfu Zhang; Manfred Jugold; Eva C Woenne; Twan Lammers; Bernd Morgenstern; Margareta M Mueller; Hanswalter Zentgraf; Michael Bock; Michael Eisenhut; Wolfhard Semmler; Fabian Kiessling
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

9.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

Authors:  Huan Meng; Min Xue; Tian Xia; Zhaoxia Ji; Derrick Y Tarn; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2011-04-27       Impact factor: 15.881

10.  A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.

Authors:  Moritz F Kircher; Umar Mahmood; Raymond S King; Ralph Weissleder; Lee Josephson
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

View more
  14 in total

1.  Controlling antibiotic release from mesoporous silica nano drug carriers via self-assembled polyelectrolyte coating.

Authors:  Tasnuva Tamanna; Jurgen B Bulitta; Aimin Yu
Journal:  J Mater Sci Mater Med       Date:  2015-02-11       Impact factor: 3.896

2.  Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.

Authors:  Abhilash Samykutty; William E Grizzle; Benjamin L Fouts; Molly W McNally; Phillip Chuong; Alexandra Thomas; Akiko Chiba; Dennis Otali; Anna Woloszynska; Neveen Said; Peter J Frederick; Jacek Jasinski; Jie Liu; Lacey R McNally
Journal:  Biomaterials       Date:  2018-08-04       Impact factor: 12.479

3.  Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

Authors:  Rolando E Yanes; Derrick Tarn; Angela A Hwang; Daniel P Ferris; Sean P Sherman; Courtney R Thomas; Jie Lu; April D Pyle; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2012-11-14       Impact factor: 13.281

4.  Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.

Authors:  James Finlay; Cai M Roberts; Juyao Dong; Jeffrey I Zink; Fuyuhiko Tamanoi; Carlotta A Glackin
Journal:  Nanomedicine       Date:  2015-06-24       Impact factor: 5.307

Review 5.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

6.  Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.

Authors:  Jie Lu; Kohei Yoshimura; Koichi Goto; Craig Lee; Ken Hamura; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 7.  Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Faris Alrumaihi; Saleh A Almatroodi; Mohammad O Alkurbi; Ghaiyda Talal Basfar; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  Int J Nanomedicine       Date:  2021-07-26

Review 8.  Mesoporous silica nanoparticles in target drug delivery system: A review.

Authors:  Charu Bharti; Upendra Nagaich; Ashok Kumar Pal; Neha Gulati
Journal:  Int J Pharm Investig       Date:  2015 Jul-Sep

9.  Delivery of cancer therapeutics using nanotechnology.

Authors:  Eun-Kyung Lim; Eunji Jang; Kwangyeol Lee; Seungjoo Haam; Yong-Min Huh
Journal:  Pharmaceutics       Date:  2013-05-15       Impact factor: 6.321

10.  Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.

Authors:  Binh Thanh Vu; Sophia Allaf Shahin; Jonas Croissant; Yevhen Fatieiev; Kotaro Matsumoto; Tan Le-Hoang Doan; Tammy Yik; Shirleen Simargi; Altagracia Conteras; Laura Ratliff; Chiara Mauriello Jimenez; Laurence Raehm; Niveen Khashab; Jean-Olivier Durand; Carlotta Glackin; Fuyuhiko Tamanoi
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.